Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Inventory (2018 - 2026)

Insmed's Inventory history spans 9 years, with the latest figure at $132.9 million for Q1 2026.

  • Quarterly Inventory rose 31.97% to $132.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $132.9 million through Mar 2026, up 31.97% year-over-year, with the annual reading at $132.1 million for FY2025, 33.97% up from the prior year.
  • Inventory came in at $132.9 million for Q1 2026, up from $132.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $132.9 million in Q1 2026 to a low of $64.1 million in Q1 2022.
  • The 5-year median for Inventory is $83.2 million (2023), against an average of $90.7 million.
  • Year-over-year, Inventory fell 1.74% in 2022 and then skyrocketed 33.97% in 2025.
  • Insmed's Inventory stood at $69.9 million in 2022, then increased by 19.06% to $83.2 million in 2023, then rose by 18.41% to $98.6 million in 2024, then surged by 33.97% to $132.1 million in 2025, then grew by 0.64% to $132.9 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Inventory are $132.9 million (Q1 2026), $132.1 million (Q4 2025), and $121.0 million (Q3 2025).